Riskpilot← Back to searchSign inGet full accessSpin-Med AB
ABActiveOrg 5566121470Skirnervägen 16Business and other management consultancy activities · NACE 7020Est. 20010 employees
Revenue 2024
SEK 132K
-76% vs 2023
EBITDA margin
-6.1%
+98% vs 2023
Equity ratio
34.9%
Financial strength
Net profit 2024
SEK -8K
+100% vs 2023
| Revenue | SEK 132K | -76% |
| EBITDA | SEK -8K | +98% |
| Net profit | SEK -8K | +100% |
| Total assets | SEK 4,3M | +239% |
| Equity | SEK 1,5M | +319% |
| Employees | 0 | — |
Legal name
Spin-Med AB
Org number
5566121470
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
29 juni 2001
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva exekutiv konsultverksamhet inom sjuk och hälso sektorn samt äga bolag inom Life Science industrin och därmed förenlig verksamhet.
Address
Skirnervägen 16
Phone
+46708769991
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 332 | 1 238 | 1 372 | 543 | 132 |
| Staff expenses | — | — | — | −682 | — |
| EBITDA | 27 | −67 | 58 | −380 | −8 |
| Depreciation & amort. | −5 | −5 | −0 | — | −0 |
| EBIT | 22 | −72 | 58 | 833 | −8 |
| Net financials | −35 | −69 | −60 | −3 201 | — |
| Profit before tax | 112 | 11 | 63 | −2 106 | −8 |
| Tax | −28 | −6 | −17 | −218 | −0 |
| Net profit | 84 | 5 | 46 | −2 324 | −8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 247 | 3 176 | 3 179 | 1 279 | 4 331 |
| Equity | 1 582 | 1 588 | 1 633 | −691 | 1 511 |
| Long-term debt | 197 | 267 | 246 | 172 | 90 |
| Short-term debt | 989 | 995 | 1 037 | 1 797 | 2 729 |
| Total debt | 1 186 | 1 262 | 1 283 | 1 969 | 2 819 |
EBITDA margin
-6.1%
This company
15.8%
Market median
-139% vs market
20202024
Equity ratio
34.9%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
-0.5%
This company
18.4%
Market median
-103% vs market
20202024
Net profit margin
-6.1%
This company
8.1%
Market median
-175% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
1.87×
This company
0.62×
Market median
-202% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ST Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Spin-Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stanislaw Tadeusz Jan Mikulowski | Chief Executive Officer | 0 companies |
| Renata Maria Mikulowska | Deputy Board Member | 0 companies |